Literature DB >> 32959352

Lung Cancer Screening Uptake: Analysis of BRFSS 2018.

Dustin Kee1, Juan Wisnivesky2, Minal S Kale2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32959352      PMCID： PMC8390735          DOI： 10.1007/s11606-020-06236-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  6 in total

1.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.

Authors:  Ahmedin Jemal; Stacey A Fedewa
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

2.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

3.  Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis.

Authors:  Whitney E Zahnd; Jan M Eberth
Journal:  Am J Prev Med       Date:  2019-06-24       Impact factor: 5.043

4.  Persistence of racial disparities in early-stage lung cancer treatment.

Authors:  Andrea Wolf; Naomi Alpert; Benjamin V Tran; Bian Liu; Raja Flores; Emanuela Taioli
Journal:  J Thorac Cardiovasc Surg       Date:  2018-12-11       Impact factor: 5.209

5.  Health Insurance Status and Clinical Cancer Screenings Among U.S. Adults.

Authors:  Guixiang Zhao; Catherine A Okoro; Jun Li; Machell Town
Journal:  Am J Prev Med       Date:  2018-01       Impact factor: 5.043

6.  Lung cancer screening: what do long-term smokers know and believe?

Authors:  Lisa Carter-Harris; DuyKhanh Pham Ceppa; Nasser Hanna; Susan M Rawl
Journal:  Health Expect       Date:  2015-12-23       Impact factor: 3.377
  6 in total
  11 in total

1.  Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.

Authors:  Randi M Williams; Tengfei Li; George Luta; Min Qi Wang; Lucile Adams-Campbell; Rafael Meza; Martin C Tammemägi; Kathryn L Taylor
Journal:  Cancer       Date:  2022-02-24       Impact factor: 6.860

2.  A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting.

Authors:  Kathryn L Taylor; Randi M Williams; Tengfei Li; George Luta; Laney Smith; Kimberly M Davis; Cassandra A Stanton; Raymond Niaura; David Abrams; Tania Lobo; Jeanne Mandelblatt; Jinani Jayasekera; Rafael Meza; Jihyoun Jeon; Pianpian Cao; Eric D Anderson
Journal:  J Natl Cancer Inst       Date:  2022-10-06       Impact factor: 11.816

3.  Improving smoking history documentation in the electronic health record for lung cancer risk assessment and screening in primary care: A case study.

Authors:  Elizabeth Peterson; Kathryn Harris; Farhood Farjah; Nkem Akinsoto; Leah M Marcotte
Journal:  Healthc (Amst)       Date:  2021-08-24

4.  Improved motivation and readiness to quit shortly after lung cancer screening: Evidence for a teachable moment.

Authors:  Randi M Williams; Marisa Cordon; Ellie Eyestone; Laney Smith; George Luta; Brady J McKee; Shawn M Regis; David B Abrams; Raymond S Niaura; Cassandra A Stanton; Vicky Parikh; Kathryn L Taylor
Journal:  Cancer       Date:  2022-02-10       Impact factor: 6.921

5.  Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.

Authors:  Iakovos Toumazis; Koen de Nijs; Pianpian Cao; Mehrad Bastani; Vidit Munshi; Kevin Ten Haaf; Jihyoun Jeon; G Scott Gazelle; Eric J Feuer; Harry J de Koning; Rafael Meza; Chung Yin Kong; Summer S Han; Sylvia K Plevritis
Journal:  JAMA Oncol       Date:  2021-12-01       Impact factor: 33.006

6.  Likelihood of Lung Cancer Screening by Poor Health Status and Race and Ethnicity in US Adults, 2017 to 2020.

Authors:  Alison S Rustagi; Amy L Byers; Salomeh Keyhani
Journal:  JAMA Netw Open       Date:  2022-03-01

7.  Engaging Patients in Smoking Cessation Treatment within the Lung Cancer Screening Setting: Lessons Learned from an NCI SCALE Trial.

Authors:  Randi M Williams; Ellie Eyestone; Laney Smith; Joanna G Philips; Julia Whealan; Marguerite Webster; Tengfei Li; George Luta; Kathryn L Taylor
Journal:  Curr Oncol       Date:  2022-03-23       Impact factor: 3.109

8.  Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening.

Authors:  Ilana B Richman; Taara V Prasad; Cary P Gross
Journal:  Prev Med Rep       Date:  2022-07-21

9.  Uptake of lung cancer screening with low-dose computed tomography in China: A multi-centre population-based study.

Authors:  Wei Cao; Fengwei Tan; Kuangyu Liu; Zheng Wu; Fei Wang; Yiwen Yu; Yan Wen; Chao Qin; Yongjie Xu; Liang Zhao; Wei Tang; Jiang Li; Xuesi Dong; Yadi Zheng; Zhuoyu Yang; Kai Su; Fang Li; Jufang Shi; Jiansong Ren; Yunyong Liu; Lianzheng Yu; Donghua Wei; Dong Dong; Ji Cao; Shaokai Zhang; Shipeng Yan; Ning Wang; Lingbin Du; Wanqing Chen; Ni Li; Jie He
Journal:  EClinicalMedicine       Date:  2022-07-29

Review 10.  Lung Cancer Screening in Asbestos-Exposed Populations.

Authors:  Steven B Markowitz
Journal:  Int J Environ Res Public Health       Date:  2022-02-25       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.